Objective. To evaluate longitudinal cognitive/behavioral change over 12 months in participants enrolled in the ALS Multicenter Cohort Study of Oxidative Stress (ALS COSMOS). Methods. We analyzed data from 294 ALS participants, 134 of whom were studied serially. Change over time was evaluated controlling for age, sex, symptom duration, education, race, and ethnicity. Using multiple regression, we evaluated associations among decline in ALS Functional Rating Scale-Revised (ALSFRS-R) scores, forced vital capacity (FVC), and cognitive/behavioral changes. Change in cognitive/behavioral subgroups was assessed using one-way analyses of covariance. Results. Participants with follow-up data had fewer baseline behavior problems compared to patients w...
Objectives: Extra-motor manifestations occur in 50% of patients with amyotrophic lateral sclerosis (...
Background: Amyotrophic Lateral Sclerosis is a multi-system disease that also affects cognition and ...
Brief screening tools that detect and differentiate patients with amyotrophic lateral sclerosis and ...
Objective. To evaluate longitudinal cognitive/behavioral change over 12 months in participants enrol...
ObjectiveTo evaluate longitudinal cognitive/behavioral change over 12 months in participants enrolle...
<p><i>Objective</i>: The study presents data on the longitudinal administration of the Italian Edinb...
Objective To elucidate the relationship between disease stage in amyotrophic lateral sclerosis (ALS)...
Objective: The study presents data on the longitudinal administration of the Italian Edinburgh Cogni...
We aimed to quantitatively characterize progressive brain network disruption in Amyotrophic Lateral ...
Previously thought to be a pure motor disease, amyotrophic lateral sclerosis (ALS) is now establishe...
doi:https://doi.org/10.1080/21678421.2017.1407794Background: Cognitive impairment affects approximat...
BackgroundTo prospectively evaluate the progression of cognitive-behavioral function in amyotrophic ...
Objective. To determine whether the neuropsychological profiles of ALS patients with (ALSC9+) and wi...
Background: A cognitive impairment, ranging from frontotemporal dementia (FTD) to milder forms of dy...
Amyotrophic Lateral Sclerosis (ALS) is a rapid and fatal neurodegenerative disease marked by progre...
Objectives: Extra-motor manifestations occur in 50% of patients with amyotrophic lateral sclerosis (...
Background: Amyotrophic Lateral Sclerosis is a multi-system disease that also affects cognition and ...
Brief screening tools that detect and differentiate patients with amyotrophic lateral sclerosis and ...
Objective. To evaluate longitudinal cognitive/behavioral change over 12 months in participants enrol...
ObjectiveTo evaluate longitudinal cognitive/behavioral change over 12 months in participants enrolle...
<p><i>Objective</i>: The study presents data on the longitudinal administration of the Italian Edinb...
Objective To elucidate the relationship between disease stage in amyotrophic lateral sclerosis (ALS)...
Objective: The study presents data on the longitudinal administration of the Italian Edinburgh Cogni...
We aimed to quantitatively characterize progressive brain network disruption in Amyotrophic Lateral ...
Previously thought to be a pure motor disease, amyotrophic lateral sclerosis (ALS) is now establishe...
doi:https://doi.org/10.1080/21678421.2017.1407794Background: Cognitive impairment affects approximat...
BackgroundTo prospectively evaluate the progression of cognitive-behavioral function in amyotrophic ...
Objective. To determine whether the neuropsychological profiles of ALS patients with (ALSC9+) and wi...
Background: A cognitive impairment, ranging from frontotemporal dementia (FTD) to milder forms of dy...
Amyotrophic Lateral Sclerosis (ALS) is a rapid and fatal neurodegenerative disease marked by progre...
Objectives: Extra-motor manifestations occur in 50% of patients with amyotrophic lateral sclerosis (...
Background: Amyotrophic Lateral Sclerosis is a multi-system disease that also affects cognition and ...
Brief screening tools that detect and differentiate patients with amyotrophic lateral sclerosis and ...